Your browser doesn't support javascript.
loading
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
Romero, Ignacio; Rubio, M Jesús; Medina, Manuel; Matias-Guiu, Xavier; Santacana, Maria; Schoenenberger, Juan-Antonio; Guerra, Eva Maria; Cortés, Alfonso; Minig, Lucas; Coronado, Pluvio; Cueva, Juan Fernando; Gómez, Lourdes; Malfettone, Andrea; Sampayo, Miguel; Llombart-Cussac, Antonio; Poveda, Andrés.
Affiliation
  • Romero I; Instituto Valenciano de Oncología, Valencia, Spain. Electronic address: iromero@fivo.org.
  • Rubio MJ; Hospital Universitario Reina Sofía de Córdoba, Córdoba, Spain.
  • Medina M; Hospital Universitario Reina Sofía de Córdoba, Córdoba, Spain.
  • Matias-Guiu X; Hospital U Arnau de Vilanova, and Hospital U de Bellvitge, IRBLLEIDA, IDIBELL, Universities of Lleida and Barcelona, CIBERONC, Spain.
  • Santacana M; Hospital U Arnau de Vilanova, and Hospital U de Bellvitge, IRBLLEIDA, IDIBELL, Universities of Lleida and Barcelona, CIBERONC, Spain.
  • Schoenenberger JA; Lleida Institute for Biomedical Research Dr. Pifarr, Foundation, IRB Lleida, Lleida, Spain.
  • Guerra EM; Hospital Ramón y Cajal, Madrid, Spain.
  • Cortés A; Hospital Ramón y Cajal, Madrid, Spain.
  • Minig L; Instituto Valenciano de Oncología, Valencia, Spain.
  • Coronado P; Hospital Clínico San Carlos, IdISSC, Universidad Complutense, Madrid, Spain.
  • Cueva JF; Hospital Clínico Universitario de Santiago, La Coruña, Spain.
  • Gómez L; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.
  • Malfettone A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.
  • Sampayo M; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.
  • Llombart-Cussac A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain; Hospital Arnau de Vilanova, Universidad Católica San Vicente Mártir, Valencia, Spain; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.
  • Poveda A; Instituto Valenciano de Oncología, Valencia, Spain; Initia Oncology, Hospital Quironsalud, Valencia, Spain.
Gynecol Oncol ; 159(3): 721-731, 2020 12.
Article in En | MEDLINE | ID: mdl-32988624
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Biomarkers, Tumor / Endometrial Neoplasms / Neoadjuvant Therapy / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Gynecol Oncol Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Piperazines / Biomarkers, Tumor / Endometrial Neoplasms / Neoadjuvant Therapy / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Gynecol Oncol Year: 2020 Document type: Article